Multi-cancer early detection (MCED) testing is generating significant excitement—but what does the evidence actually support? In this data-driven session, Dr. Candace Westgate will review the current science behind MCED technologies, including test performance, clinical utility, and implementation challenges. Drawing on her experience integrating preventive tools into practice, she’ll explore where MCED testing fits into the future of cancer screening and how clinicians can approach its use with clarity and caution.

Candace Westgate, DO, FACOG, DipABLM, is a board-certified OB/GYN and lifestyle medicine physician dedicated to advancing preventive care and whole-person health. She serves as the Medical Director of Blue Zones and Adventist Health’s WELLthy Lifestyle Program, where she leads community-based initiatives focused on reducing chronic disease through lifestyle intervention. Dr. Westgate specializes in women’s health across the lifespan and is passionate about empowering patients with the tools to live healthier, more purposeful lives through personalized, evidence-based care.